Landscapes / Companies
MacroGenics not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
5
in active trials · 27 in all
Trials
5 active
39 since 2021
Drugs5
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Monoclonal antibody |
Phase 2 | Jul 2027Phase 2 trial completes | |||
| How it works | An antibody | ||||
| Next date | Jul 2027 · Phase 2 trial completes | ||||
| Also tested for | Platinum-resistant Ovarian Cancer, Platinum-Resistant Fallopian Tube Carcinoma and 9 more | ||||
| Open drug page | |||||
— |
Phase 1 | Nov 2026soonPhase 1 trial completes | |||
| Next date | Nov 2026 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumors, NSCLC Adenocarcinoma and 3 more | ||||
| Open drug page | |||||
— |
Phase 1 | Nov 2026soonPhase 1 trial completes | |||
| Next date | Nov 2026 · Phase 1 trial completes | ||||
| Also tested for | Leukemia, Acute Myeloid, Myelodysplastic Syndromes and 6 more | ||||
| Open drug page | |||||
— |
Phase 1 | Sep 2028Phase 1 trial completes | |||
| Next date | Sep 2028 · Phase 1 trial completes | ||||
| Also tested for | Urothelial Cancer, GastroEsophageal Cancer and 4 more | ||||
| Open drug page | |||||
Monoclonal antibody |
Phase 1 | Oct 2028Phase 1 trial completes | |||
| How it works | An antibody | ||||
| Next date | Oct 2028 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumor, Advanced Cancer and 20 more | ||||
| Open drug page | |||||
About
- No active trial
- 22 other drugs
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021